Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 36

1.

Optimal provision of needle and syringe programmes for injecting drug users: A systematic review.

Jones L, Pickering L, Sumnall H, McVeigh J, Bellis MA.

Int J Drug Policy. 2010 Sep;21(5):335-42. doi: 10.1016/j.drugpo.2010.02.001. Epub 2010 Feb 26. Review.

PMID:
20189375
2.

Evidence for the effectiveness of sterile injecting equipment provision in preventing hepatitis C and human immunodeficiency virus transmission among injecting drug users: a review of reviews.

Palmateer N, Kimber J, Hickman M, Hutchinson S, Rhodes T, Goldberg D.

Addiction. 2010 May;105(5):844-59. doi: 10.1111/j.1360-0443.2009.02888.x. Epub 2010 Mar 2. Review.

PMID:
20219055
3.

Integrating multiple programme and policy approaches to hepatitis C prevention and care for injection drug users: a comprehensive approach.

Birkhead GS, Klein SJ, Candelas AR, O'Connell DA, Rothman JR, Feldman IS, Tsui DS, Cotroneo RA, Flanigan CA.

Int J Drug Policy. 2007 Oct;18(5):417-25. Epub 2007 Feb 20. Review.

PMID:
17854731
4.

The effectiveness and safety of syringe vending machines as a component of needle syringe programmes in community settings.

Islam M, Wodak A, Conigrave KM.

Int J Drug Policy. 2008 Dec;19(6):436-41. Epub 2007 Sep 4. Review.

PMID:
17766100
5.

The provision of non-needle/syringe drug injecting paraphernalia in the primary prevention of HCV among IDU: a systematic review.

Gillies M, Palmateer N, Hutchinson S, Ahmed S, Taylor A, Goldberg D.

BMC Public Health. 2010 Nov 23;10:721. doi: 10.1186/1471-2458-10-721. Review.

6.

The role of needle exchange programs in HIV prevention.

Vlahov D, Junge B.

Public Health Rep. 1998 Jun;113 Suppl 1:75-80. Review.

7.

Syringe exchange: HIV prevention, key findings, and future directions.

Paone D, Des Jarlais DC, Gangloff R, Milliken J, Friedman SR.

Int J Addict. 1995;30(12):1647-83. Review.

PMID:
8557411
8.

HIV prevention, treatment, and care services for people who inject drugs: a systematic review of global, regional, and national coverage.

Mathers BM, Degenhardt L, Ali H, Wiessing L, Hickman M, Mattick RP, Myers B, Ambekar A, Strathdee SA; 2009 Reference Group to the UN on HIV and Injecting Drug Use.

Lancet. 2010 Mar 20;375(9719):1014-28. doi: 10.1016/S0140-6736(10)60232-2. Epub 2010 Feb 26. Review.

PMID:
20189638
9.

Epidemiology of hepatitis C virus infection among injection drug users in China: systematic review and meta-analysis.

Xia X, Luo J, Bai J, Yu R.

Public Health. 2008 Oct;122(10):990-1003. doi: 10.1016/j.puhe.2008.01.014. Epub 2008 May 19. Review.

PMID:
18486955
11.

Outreach-based HIV prevention for injecting drug users: a review of published outcome data.

Coyle SL, Needle RH, Normand J.

Public Health Rep. 1998 Jun;113 Suppl 1:19-30. Review.

12.

Systematic review of HIV and HCV infection among drug users in China.

Bao YP, Liu ZM.

Int J STD AIDS. 2009 Jun;20(6):399-405. doi: 10.1258/ijsa.2008.008362. Review.

PMID:
19451325
13.

Strategies to improve access to sterile syringes for injection drug users.

Rich JD, Wolf FA, Macalino G.

AIDS Read. 2002 Dec;12(12):527-35. Review.

PMID:
12518719
14.

Epidemiology of hepatitis C virus infection among injecting drug users in Australia.

Crofts N, Jolley D, Kaldor J, van Beek I, Wodak A.

J Epidemiol Community Health. 1997 Dec;51(6):692-7. Review.

15.

Harm reduction theories and strategies for control of human immunodeficiency virus: a review of the literature.

Hilton BA, Thompson R, Moore-Dempsey L, Janzen RG.

J Adv Nurs. 2001 Feb;33(3):357-70. Review.

PMID:
11251723
16.

[Intravenous drug use and the spread of HIV; an international perspective].

Meijerink H, van Crevel R, van der Ven AJ.

Ned Tijdschr Geneeskd. 2013;157(21):A5690. Review. Dutch.

PMID:
23693006
17.

High coverage needle/syringe programs for people who inject drugs in low and middle income countries: a systematic review.

Des Jarlais DC, Feelemyer JP, Modi SN, Abdul-Quader A, Hagan H.

BMC Public Health. 2013 Jan 19;13:53. doi: 10.1186/1471-2458-13-53. Review.

18.

Interventions to prevent HIV and Hepatitis C in people who inject drugs: a review of reviews to assess evidence of effectiveness.

MacArthur GJ, van Velzen E, Palmateer N, Kimber J, Pharris A, Hope V, Taylor A, Roy K, Aspinall E, Goldberg D, Rhodes T, Hedrich D, Salminen M, Hickman M, Hutchinson SJ.

Int J Drug Policy. 2014 Jan;25(1):34-52. doi: 10.1016/j.drugpo.2013.07.001. Epub 2013 Aug 21. Review.

PMID:
23973009
19.

Effectiveness of structural-level needle/syringe programs to reduce HCV and HIV infection among people who inject drugs: a systematic review.

Abdul-Quader AS, Feelemyer J, Modi S, Stein ES, Briceno A, Semaan S, Horvath T, Kennedy GE, Des Jarlais DC.

AIDS Behav. 2013 Nov;17(9):2878-92. doi: 10.1007/s10461-013-0593-y. Review.

PMID:
23975473
20.

Are needle and syringe programmes associated with a reduction in HIV transmission among people who inject drugs: a systematic review and meta-analysis.

Aspinall EJ, Nambiar D, Goldberg DJ, Hickman M, Weir A, Van Velzen E, Palmateer N, Doyle JS, Hellard ME, Hutchinson SJ.

Int J Epidemiol. 2014 Feb;43(1):235-48. doi: 10.1093/ije/dyt243. Epub 2013 Dec 27. Review.

Items per page

Supplemental Content

Write to the Help Desk